Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

September 5, 2020
Review
Open Access

Novel Multitarget Therapies for Lung Cancer and Respiratory Disease

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Masako YumuraYoshihiro Nishimura
September 22, 2020
Review

Management of immune checkpoint inhibitors-induced liver toxicity in cancer

Bulletin du cancer
Fanny LebosséPhilippe Merle
September 19, 2020

In vivo assessment of aminopeptidase N (APN/CD13) specificity of different 68 Ga-labelled NGR derivatives using PET/MRI imaging

International Journal of Pharmaceutics
Adrienn KisGyörgy Trencsényi
August 28, 2020
Review
Open Access

Angiogenesis Inhibition in Prostate Cancer: An Update

Cancers
Chandrani SarkarDebanjan Chakroborty
September 10, 2020
Review

Implications of flavonoids as potential modulators of cancer neovascularity

Journal of Cancer Research and Clinical Oncology
Alena LiskovaPeter Kubatka
August 29, 2020
Review
Open Access

Front-Line Maintenance Therapy in Advanced Ovarian Cancer-Current Advances and Perspectives

Cancers
Thibaut ReverdyGilles Freyer
August 28, 2020
Open Access

IL-31 induces antitumor immunity in breast carcinoma

Journal for Immunotherapy of Cancer
Tal KanYuval Shaked
September 7, 2020

Myeloid-Derived Suppressor Cells Improve Corneal Graft Survival through Suppressing Angiogenesis and Lymphangiogenesis

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Yuerong RenYan He
September 1, 2020

Nanoparticle Delivery of MnO2 and Anti-angiogenic Therapy to Overcome Hypoxia-Driven Tumor Escape and Suppress Hepatocellular Carcinoma

ACS Applied Materials & Interfaces
Chih-Chun ChangYunching Chen
September 10, 2020
Open Access

WAVE2 Enhanced Hepatic Stellate Cells Activity in Colorectal Liver Metastases

Cancer Management and Research
Fengbo TanYiming Tao
September 17, 2020
Open Access

Intra-Tumoral Angiogenesis Is Associated with Inflammation, Immune Reaction and Metastatic Recurrence in Breast Cancer

International Journal of Molecular Sciences
Masanori OshiKazuaki Takabe
September 19, 2020
Open Access

Moxibustion Enhances Chemotherapy of Breast Cancer by Affecting Tumor Microenvironment

Cancer Management and Research
Ning XueJianbin Zhang
August 30, 2020
Review
Open Access

Interaction between Immunotherapy and Antiangiogenic Therapy for Cancer

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Koichi FurukawaYoshihiro Nishimura
September 10, 2020
Open Access

TLR family gene expression in relation to the HIF1α and the VEGFR pathway activation in endometrial cancer

Ginekologia polska
Katarzyna M Wojcik-KrowirandaMagdalena Brys
September 13, 2020

Multimodal imaging features and clinical relevance of subretinal lipid globules

American Journal of Ophthalmology
Pedro Fernández-AvellanedaRosa Dolz-Marco
September 2, 2020
Open Access

Investigating Glioblastoma Response to Hypoxia

Biomedicines
Agathe L ChédevillePatricia A Madureira

Sign up to follow this feed and discover related papers.

Related Feeds

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Genomics

Cancer genomics employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research here.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

© 2020 Meta ULC. All rights reserved
/feed-previews/angiogenesis-inhibitors-to-treat/91da804f-fb64-43c0-b5d5-7a6ecb289e43